These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 12684410

  • 1. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer.
    Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ, Lu CH, Chiou LC.
    Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410
    [Abstract] [Full Text] [Related]

  • 2. Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma.
    Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ.
    Gynecol Oncol; 2000 Jul; 78(1):10-5. PubMed ID: 10873402
    [Abstract] [Full Text] [Related]

  • 3. KAI1 protein is down-regulated during the progression of human breast cancer.
    Yang X, Wei L, Tang C, Slack R, Montgomery E, Lippman M.
    Clin Cancer Res; 2000 Sep; 6(9):3424-9. PubMed ID: 10999724
    [Abstract] [Full Text] [Related]

  • 4. Loss of KAI1 expression in the progression of colorectal cancer.
    Lombardi DP, Geradts J, Foley JF, Chiao C, Lamb PW, Barrett JC.
    Cancer Res; 1999 Nov 15; 59(22):5724-31. PubMed ID: 10582691
    [Abstract] [Full Text] [Related]

  • 5. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T, Frauman AG.
    J Pathol; 1999 Aug 15; 188(4):382-8. PubMed ID: 10440748
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT, Suzuki H, Pin SS, Bova GS, Schalken JA, Isaacs WB, Barrett JC, Isaacs JT.
    Cancer Res; 1996 Oct 01; 56(19):4387-90. PubMed ID: 8813131
    [Abstract] [Full Text] [Related]

  • 7. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
    Adachi M, Taki T, Ieki Y, Huang CL, Higashiyama M, Miyake M.
    Cancer Res; 1996 Apr 15; 56(8):1751-5. PubMed ID: 8620488
    [Abstract] [Full Text] [Related]

  • 8. Frequent downregulation of the KAI1(CD82) metastasis suppressor protein in human cancer cell lines.
    White A, Lamb PW, Barrett JC.
    Oncogene; 1998 Jun 18; 16(24):3143-9. PubMed ID: 9671393
    [Abstract] [Full Text] [Related]

  • 9. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
    Clin Cancer Res; 2005 Jun 15; 11(12):4357-64. PubMed ID: 15958618
    [Abstract] [Full Text] [Related]

  • 10. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
    Muneyuki T, Watanabe M, Yamanaka M, Shiraishi T, Isaji S.
    Anticancer Res; 2001 Jun 15; 21(5):3581-7. PubMed ID: 11848527
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of KAI1 metastasis suppressor protein is associated with a dismal prognosis in epithelial ovarian cancer.
    Schindl M, Birner P, Breitenecker G, Oberhuber G.
    Gynecol Oncol; 2001 Nov 15; 83(2):244-8. PubMed ID: 11606078
    [Abstract] [Full Text] [Related]

  • 12. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases.
    Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Büchler MW.
    Cancer Res; 1996 Nov 01; 56(21):4876-80. PubMed ID: 8895737
    [Abstract] [Full Text] [Related]

  • 13. Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer.
    Yang JL, Jackson P, Yu Y, Russell PJ, Markovic B, Crowe PJ.
    Anticancer Res; 2002 Nov 01; 22(6A):3337-42. PubMed ID: 12530084
    [Abstract] [Full Text] [Related]

  • 14. KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma.
    Guo XZ, Friess H, Di Mola FF, Heinicke JM, Abou-Shady M, Graber HU, Baer HU, Zimmermann A, Korc M, Büchler MW.
    Hepatology; 1998 Dec 01; 28(6):1481-8. PubMed ID: 9828210
    [Abstract] [Full Text] [Related]

  • 15. CD82, and CD63 in thyroid cancer.
    Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, Köhrle J, Holzhausen HJ, Kehlen A, Klonisch T, Finke R, Dralle H, Hoang-Vu C.
    Int J Mol Med; 2004 Oct 01; 14(4):517-27. PubMed ID: 15375577
    [Abstract] [Full Text] [Related]

  • 16. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI, Shin MK, Lee JW, Chung JH, Lee MH.
    Oncol Rep; 2009 Jan 01; 21(1):159-64. PubMed ID: 19082457
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
    Yang X, Wei LL, Tang C, Slack R, Mueller S, Lippman ME.
    Cancer Res; 2001 Jul 01; 61(13):5284-8. PubMed ID: 11431371
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of KAI1 mRNA in localised prostate cancer and its bony metastases does not correlate with p53 overexpression.
    Jackson P, Ow K, Yardley G, Delprado W, Quinn DI, Yang JL, Russell PJ.
    Prostate Cancer Prostatic Dis; 2003 Jul 01; 6(2):174-81. PubMed ID: 12806379
    [Abstract] [Full Text] [Related]

  • 19. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K, Ono K, Suzuki H, Tanaka C, Yakushiji T, Yamamoto N, Yokoe H, Tanzawa H.
    Clin Cancer Res; 2002 Mar 01; 8(3):828-35. PubMed ID: 11895916
    [Abstract] [Full Text] [Related]

  • 20. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers.
    Yu Y, Yang JL, Markovic B, Jackson P, Yardley G, Barrett J, Russell PJ.
    Clin Cancer Res; 1997 Jul 01; 3(7):1045-9. PubMed ID: 9815782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.